Outcomes validate the company’s PTAP platform as a foundation for a rapid, adaptable antiviral modality across animal and ...
Scientists used CRISPR to disable the NRF2 gene, restoring chemotherapy sensitivity in lung cancer cells and slowing tumor ...
News-Medical.Net on MSN
Innovative CRISPR strategy resensitizes lung cancer to treatment
In a major step forward for cancer care, researchers at ChristianaCare's Gene Editing Institute have shown that disabling the ...
Genetic medicines-focused Scribe Therapeutics is racing toward the clinic on the heels of a preclinical data drop for three ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback